{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:53:53Z","timestamp":1790776433754,"version":"4.1.0"},"reference-count":146,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007875","name":"Tulane University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005347","name":"American Association for the Study of Liver Diseases","doi-asserted-by":"publisher","award":["PNC23-183584"],"award-info":[{"award-number":["PNC23-183584"]}],"id":[{"id":"10.13039\/100005347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["U54-GM104940"],"award-info":[{"award-number":["U54-GM104940"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R21-AA031033"],"award-info":[{"award-number":["R21-AA031033"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["K01-AA031305"],"award-info":[{"award-number":["K01-AA031305"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ajpath.2025.04.015","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T07:56:18Z","timestamp":1746777378000},"page":"35-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cholestasis in Alcohol-Associated Liver Disease"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4012-9557","authenticated-orcid":false,"given":"Shengmin","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8576-6093","authenticated-orcid":false,"given":"Xiao-Ming","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2025.04.015_bib1","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jhep.2019.05.020","article-title":"Natural history of histologically proven alcohol-related liver disease: a systematic review","volume":"71","author":"Parker","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib2","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the global burden of disease study 2016","volume":"390","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2025.04.015_bib3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jhep.2013.03.007","article-title":"Global burden of alcoholic liver diseases","volume":"59","author":"Rehm","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib4","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/hep.30369","article-title":"Alcohol-related liver disease: areas of consensus, unmet needs and opportunities for further study","volume":"69","author":"Szabo","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.04.015_bib5","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.mayocp.2020.01.015","article-title":"Cholestatic liver diseases: a primer for generalists and subspecialists","volume":"95","author":"Hilscher","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ajpath.2025.04.015_bib6","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/hep.28530","article-title":"Alcoholic hepatitis: translational approaches to develop targeted therapies","volume":"64","author":"Mandrekar","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.04.015_bib7","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1053\/j.gastro.2014.01.018","article-title":"A histologic scoring system for prognosis of patients with alcoholic hepatitis","volume":"146","author":"Altamirano","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2025.04.015_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/614081","article-title":"Alkaline phosphatase: the next independent predictor of the poor 90-day outcome in alcoholic hepatitis","volume":"2013","author":"Kasztelan-Szczerbinska","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ajpath.2025.04.015_bib9","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","article-title":"Bile acids: regulation of synthesis","volume":"50","author":"Chiang","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpath.2025.04.015_bib10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jhep.2024.09.032","article-title":"Bile acid metabolism and signalling in liver disease","volume":"82","author":"Fuchs","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib11","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/s41586-023-06990-w","article-title":"Bile salt hydrolase catalyses formation of amine-conjugated bile acids","volume":"626","author":"Rimal","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2025.04.015_bib12","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41586-024-07017-8","article-title":"Bile salt hydrolase acyltransferase activity expands bile acid diversity","volume":"626","author":"Guzior","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2025.04.015_bib13","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41564-023-01337-7","article-title":"Bile salt hydrolases shape the bile acid landscape and restrict Clostridioides difficile growth in the murine gut","volume":"8","author":"Foley","year":"2023","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstrom","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.ajpath.2025.04.015_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib16","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1053\/j.gastro.2011.07.046","article-title":"Bile acid is a host factor that regulates the composition of the cecal microbiota in rats","volume":"141","author":"Islam","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2025.04.015_bib17","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MOG.0000000000000057","article-title":"Bile acids and the gut microbiome","volume":"30","author":"Ridlon","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib18","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2172671","article-title":"Bile acids as modulators of gut microbiota composition and function","volume":"15","author":"Larabi","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.ajpath.2025.04.015_bib19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","article-title":"Bile acids and the gut microbiota: metabolic interactions and impacts on disease","volume":"21","author":"Collins","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib20","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1194\/jlr.R900012-JLR200","article-title":"Bile acid transporters","volume":"50","author":"Dawson","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpath.2025.04.015_bib21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-3-642-14541-4_4","article-title":"Role of the intestinal bile acid transporters in bile acid and drug disposition","author":"Dawson","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf4823","article-title":"Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice","volume":"8","author":"Rao","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ajpath.2025.04.015_bib23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev-nutr-082018-124344","article-title":"Bile acids as metabolic regulators and nutrient sensors","volume":"39","author":"Chiang","year":"2019","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.ajpath.2025.04.015_bib24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mam.2017.06.001","article-title":"Mechanisms of bile acid mediated inflammation in the liver","volume":"56","author":"Li","year":"2017","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.ajpath.2025.04.015_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2024-100074","article-title":"Bile acids regulation of cellular stress responses in liver physiology and diseases","volume":"2","author":"Li","year":"2024","journal-title":"eGastroenterology"},{"key":"10.1016\/j.ajpath.2025.04.015_bib26","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","article-title":"Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology","volume":"19","author":"Fuchs","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib27","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1001\/archinte.159.22.2647","article-title":"The continuing importance of bile acids in liver and intestinal disease","volume":"159","author":"Hofmann","year":"1999","journal-title":"Arch Internal Med"},{"key":"10.1016\/j.ajpath.2025.04.015_bib28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1194\/jlr.C120000621","article-title":"Is CYP2C70 the key to new mouse models to understand bile acids in humans?","volume":"61","author":"Guo","year":"2020","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpath.2025.04.015_bib29","article-title":"Mechanism of bile acid in regulating platelet function and thrombotic diseases","volume":"11","author":"Zhou","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.ajpath.2025.04.015_bib30","doi-asserted-by":"crossref","DOI":"10.1080\/09537104.2024.2322733","article-title":"The bile acid receptor TGR5 inhibits platelet activation and thrombus formation","volume":"35","author":"Reusswig","year":"2024","journal-title":"Platelets"},{"key":"10.1016\/j.ajpath.2025.04.015_bib31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2022.02.030","article-title":"Loss of SIRT5 promotes bile acid-induced immunosuppressive microenvironment and hepatocarcinogenesis","volume":"77","author":"Sun","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib32","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00018-022-04278-2","article-title":"The role of bile acids in carcinogenesis","volume":"79","author":"Rezen","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ajpath.2025.04.015_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108238","article-title":"Bile acid metabolism and signaling, the microbiota, and metabolic disease","volume":"237","author":"Cai","year":"2022","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ajpath.2025.04.015_bib34","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.apsb.2021.12.011","article-title":"Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases","volume":"12","author":"Guan","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.ajpath.2025.04.015_bib35","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/s42255-023-00844-5","article-title":"CRAT links cholesterol metabolism to innate immune responses in the heart","volume":"5","author":"Mao","year":"2023","journal-title":"Nat Metab"},{"key":"10.1016\/j.ajpath.2025.04.015_bib36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","article-title":"Gut microbiota-derived metabolites as key actors in inflammatory bowel disease","volume":"17","author":"Lavelle","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","article-title":"Gut microbiome structure and metabolic activity in inflammatory bowel disease","volume":"4","author":"Franzosa","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib38","article-title":"Neuroactive metabolites and bile acids are altered in extremely premature infants with brain injury","volume":"5","author":"Pristner","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ajpath.2025.04.015_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106943","article-title":"Bile acid metabolism regulatory network orchestrates bone homeostasis","volume":"196","author":"Xiang","year":"2023","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ajpath.2025.04.015_bib40","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.tim.2022.10.003","article-title":"Gut microbiota-bile acid-skeletal muscle axis","volume":"31","author":"Mancin","year":"2023","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib41","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.chom.2022.02.004","article-title":"Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis","volume":"30","author":"Cai","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ajpath.2025.04.015_bib42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control T(H)17 and T(reg) cell differentiation","volume":"576","author":"Hang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2025.04.015_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13578-023-01035-1","article-title":"Bile acid-mediated signaling in cholestatic liver diseases","volume":"13","author":"Zeng","year":"2023","journal-title":"Cell Biosci"},{"key":"10.1016\/j.ajpath.2025.04.015_bib44","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/eci.12128","article-title":"Intrahepatic cholestasis in common chronic liver diseases","volume":"43","author":"Jungst","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ajpath.2025.04.015_bib45","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jhep.2017.04.026","article-title":"Biliary bile acids in hepatobiliary injury - what is the link?","volume":"67","author":"Fickert","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib46","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.jhep.2020.12.010","article-title":"Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB\/c.Abcb4(-\/-) mouse model of PFIC3","volume":"74","author":"Wei","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib47","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1053\/j.gastro.2010.09.004","article-title":"Pathogenesis of cholestatic liver disease and therapeutic approaches","volume":"139","author":"Hirschfield","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2025.04.015_bib48","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.livres.2021.08.001","article-title":"Gut microbiome in liver pathophysiology and cholestatic liver disease","volume":"5","author":"Yan","year":"2021","journal-title":"Liver Res"},{"key":"10.1016\/j.ajpath.2025.04.015_bib49","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/gutjnl-2021-324305","article-title":"Novel therapeutic targets for cholestatic and fatty liver disease","volume":"71","author":"Trauner","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2025.04.015_bib50","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1089-3261(05)70086-6","article-title":"Cholestasis and alcoholic liver disease","volume":"3","author":"Tung","year":"1999","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.ajpath.2025.04.015_bib51","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhep.2018.03.031","article-title":"Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis","volume":"69","author":"Brandl","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib52","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/hep4.1885","article-title":"Development of alcohol-associated hepatitis is associated with specific changes in gut-modified bile acids","volume":"6","author":"Muthiah","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.ajpath.2025.04.015_bib53","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/apt.14949","article-title":"Bile acid homeostasis and intestinal dysbiosis in alcoholic hepatitis","volume":"48","author":"Ciocan","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ajpath.2025.04.015_bib54","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/hep4.1322","article-title":"Serum metabolomic profiling identifies key metabolic signatures associated with pathogenesis of alcoholic liver disease in humans","volume":"3","author":"Yang","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.ajpath.2025.04.015_bib55","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41575-018-0099-1","article-title":"Alcohol, liver disease and the gut microbiota","volume":"16","author":"Bajaj","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib56","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/acer.12704","article-title":"Alcoholic liver disease: the gut microbiome and liver cross talk","volume":"39","author":"Hartmann","year":"2015","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.ajpath.2025.04.015_bib57","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1097\/HEP.0000000000000924","article-title":"Gut-liver axis: recent concepts in pathophysiology in alcohol-associated liver disease","volume":"80","author":"Raya","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.04.015_bib58","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/hep.29676","article-title":"Modulation of the intestinal bile acid\/farnesoid X receptor\/fibroblast growth factor 15 axis improves alcoholic liver disease in mice","volume":"67","author":"Hartmann","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.04.015_bib59","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/hep.31178","article-title":"Fecal microbiome distinguishes alcohol consumption from alcoholic hepatitis but does not discriminate disease severity","volume":"72","author":"Smirnova","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.04.015_bib60","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2025.04.015_bib61","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2015-310585","article-title":"Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease","volume":"65","author":"Llopis","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2025.04.015_bib62","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep4.1679","article-title":"Exosome-like nanoparticles from lactobacillus Rhamnosusgg protect against alcohol-associated liver disease through intestinal aryl hydrocarbon receptor in mice","volume":"5","author":"Gu","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.ajpath.2025.04.015_bib63","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1136\/gutjnl-2018-317232","article-title":"Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice","volume":"68","author":"Hendrikx","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2025.04.015_bib64","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/gutjnl-2016-313432","article-title":"Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease","volume":"67","author":"Grander","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2025.04.015_bib65","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1572-0241.1999.00797.x","article-title":"Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage","volume":"94","author":"Keshavarzian","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib66","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2008.10.028","article-title":"Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats","volume":"50","author":"Keshavarzian","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib67","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1136\/gutjnl-2014-308410","article-title":"Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis","volume":"64","author":"Dubuquoy","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2025.04.015_bib68","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1002\/hep.30472","article-title":"Ductular reaction cells display an inflammatory profile and recruit neutrophils in alcoholic hepatitis","volume":"69","author":"Aguilar-Bravo","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.04.015_bib69","first-page":"342","article-title":"Neutrophils interact with cholangiocytes to cause cholestatic changes in alcoholic hepatitis","volume":"70","author":"Takeuchi","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2025.04.015_bib70","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1136\/gutjnl-2021-324295","article-title":"Clinical, histological and molecular profiling of different stages of alcohol-related liver disease","volume":"71","author":"Ventura-Cots","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2025.04.015_bib71","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1038\/s41467-019-11004-3","article-title":"Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis","volume":"10","author":"Argemi","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2025.04.015_bib72","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jhep.2023.04.013","article-title":"Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming","volume":"79","author":"Aguilar-Bravo","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib73","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/hep.30228","article-title":"Effects of endotoxin on type 3 inositol 1,4,5-trisphosphate receptor in human cholangiocytes","volume":"69","author":"Franca","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.04.015_bib74","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/hep.31228","article-title":"Intestinal microbiome-macrophage crosstalk contributes to cholestatic liver disease by promoting intestinal permeability in mice","volume":"72","author":"Isaacs-Ten","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.04.015_bib75","doi-asserted-by":"crossref","DOI":"10.1172\/JCI132305","article-title":"Bile acid-activated macrophages promote biliary epithelial cell proliferation through integrin alphavbeta6 upregulation following liver injury","volume":"131","author":"Guillot","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2025.04.015_bib76","doi-asserted-by":"crossref","first-page":"89","DOI":"10.14218\/JCTH.2017.00054","article-title":"Alcoholic hepatitis: lost in translation","volume":"6","author":"Woolbright","year":"2018","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib77","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1194\/jlr.M071183","article-title":"Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans","volume":"57","author":"Takahashi","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpath.2025.04.015_bib78","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1194\/jlr.RA119000395","article-title":"Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition","volume":"61","author":"Honda","year":"2020","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpath.2025.04.015_bib79","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1194\/jlr.RA119000243","article-title":"A human-like bile acid pool induced by deletion of hepatic Cyp2c70 modulates effects of FXR activation in mice","volume":"61","author":"de Boer","year":"2020","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpath.2025.04.015_bib80","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/acer.14234","article-title":"A novel mouse model of acute-on-chronic cholestatic alcoholic liver disease: a systems biology comparison with human alcoholic hepatitis","volume":"44","author":"Furuya","year":"2020","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.ajpath.2025.04.015_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2024.101446","article-title":"A novel multi-organ male model of alcohol-induced acute-on-chronic liver failure reveals NET-mediated hepatocellular death, which is prevented by RIPK3 inhibition","volume":"19","author":"Ortega-Ribera","year":"2025","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib82","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/s41374-020-0439-y","article-title":"Enhanced alcoholic liver disease in mice with intestine-specific farnesoid X receptor deficiency","volume":"100","author":"Huang","year":"2020","journal-title":"Lab Invest"},{"key":"10.1016\/j.ajpath.2025.04.015_bib83","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000566","article-title":"Cholestatic insult triggers alcohol-associated hepatitis in mice","volume":"8","author":"Yan","year":"2024","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.ajpath.2025.04.015_bib84","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/j.2040-4603.2013.tb00517.x","article-title":"Bile acid metabolism and signaling","volume":"3","author":"Chiang","year":"2013","journal-title":"Compr Physiol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib85","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrgastro.2013.151","article-title":"Bile acid receptors as targets for drug development","volume":"11","author":"Schaap","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib86","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/s41401-022-00880-z","article-title":"Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease","volume":"43","author":"Jiao","year":"2022","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.ajpath.2025.04.015_bib87","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1124\/dmd.121.000643","article-title":"Molecular regulation of bile acid homeostasis","volume":"50","author":"Choudhuri","year":"2022","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.ajpath.2025.04.015_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111618","article-title":"Discovery of farnesoid X receptor and its role in bile acid metabolism","volume":"548","author":"Chiang","year":"2022","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib89","doi-asserted-by":"crossref","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","article-title":"Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy","volume":"318","author":"Chiang","year":"2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib90","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.apsb.2014.12.011","article-title":"Role of farnesoid X receptor and bile acids in alcoholic liver disease","volume":"5","author":"Manley","year":"2015","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.ajpath.2025.04.015_bib91","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/hep4.1256","article-title":"FXR and TGR5 agonists ameliorate liver injury, steatosis, and inflammation after binge or prolonged alcohol feeding in mice","volume":"2","author":"Iracheta-Vellve","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.ajpath.2025.04.015_bib92","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.dld.2018.12.026","article-title":"FXR deficiency alters bile acid pool composition and exacerbates chronic alcohol induced liver injury","volume":"51","author":"Kong","year":"2019","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ajpath.2025.04.015_bib93","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/liv.15374","article-title":"Altered ethanol metabolism and increased oxidative stress enhance alcohol-associated liver injury in farnesoid X receptor-deficient mice","volume":"43","author":"Morel","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.ajpath.2025.04.015_bib94","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s12072-023-10621-x","article-title":"FXR overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in alcoholic liver disease","volume":"18","author":"Li","year":"2024","journal-title":"Hepatol Int"},{"key":"10.1016\/j.ajpath.2025.04.015_bib95","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.dld.2018.04.009","article-title":"FXR deletion in hepatocytes does not affect the severity of alcoholic liver disease in mice","volume":"50","author":"Zhang","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ajpath.2025.04.015_bib96","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000138","article-title":"Tgr5-\/- mice are protected from ethanol-induced metabolic alterations through enhanced leptin and Fgf21 signaling","volume":"7","author":"Pokhrel","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.ajpath.2025.04.015_bib97","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jcmgh.2021.12.001","article-title":"Bile acid-mediated activation of brown fat protects from alcohol-induced steatosis and liver injury in mice","volume":"13","author":"Fan","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib98","article-title":"Bile acid-receptor TGR5 deficiency worsens liver injury in alcohol-fed mice by inducing intestinal microbiota dysbiosis","volume":"3","author":"Spatz","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.ajpath.2025.04.015_bib99","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/hep.24681","article-title":"Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes","volume":"55","author":"Studer","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.04.015_bib100","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.29076","article-title":"The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice","volume":"65","author":"Wang","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.04.015_bib101","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/hep.27592","article-title":"Conjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression","volume":"61","author":"Nagahashi","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.04.015_bib102","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.dld.2019.03.020","article-title":"The role of sphingosine kinase 2 in alcoholic liver disease","volume":"51","author":"Kwong","year":"2019","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ajpath.2025.04.015_bib103","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/hep.31321","article-title":"Inhibition of sphingosine-1-phosphate-induced Th17 cells ameliorates alcohol-associated steatohepatitis in mice","volume":"73","author":"Chu","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.04.015_bib104","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1016\/j.apsb.2024.08.029","article-title":"Activation of pregnane X receptor sensitizes alcoholic steatohepatitis by transactivating fatty acid binding protein 4","volume":"14","author":"Zhang","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.ajpath.2025.04.015_bib105","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0022-2275(20)30141-3","article-title":"Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor","volume":"43","author":"Kliewer","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpath.2025.04.015_bib106","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jsbmb.2011.06.012","article-title":"FXR and PXR: potential therapeutic targets in cholestasis","volume":"130","author":"Jonker","year":"2012","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1074\/jbc.M117.815217","article-title":"Pregnane X receptor promotes ethanol-induced hepatosteatosis in mice","volume":"293","author":"Choi","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2025.04.015_bib108","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/jpet.117.244665","article-title":"Role of the pregnane X receptor in binge ethanol-induced steatosis and hepatotoxicity","volume":"365","author":"Choi","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ajpath.2025.04.015_bib109","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tox.2005.07.005","article-title":"Chronic ethanol exposure downregulates hepatic expression of pregnane X receptor and P450 3A11 in female ICR mice","volume":"215","author":"Wang","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.ajpath.2025.04.015_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116416","article-title":"Molecular targets of PXR-dependent ethanol-induced hepatotoxicity in female mice","volume":"228","author":"Choi","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib111","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1124\/jpet.115.224295","article-title":"Receptor-humanized mice recapitulate gender differences in ethanol metabolism but not hepatotoxicity","volume":"354","author":"Spruiell","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ajpath.2025.04.015_bib112","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/labinvest.2011.68","article-title":"The nuclear receptor CAR modulates alcohol-induced liver injury","volume":"91","author":"Chen","year":"2011","journal-title":"Lab Invest"},{"key":"10.1016\/j.ajpath.2025.04.015_bib113","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1073\/pnas.0409794102","article-title":"Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury","volume":"102","author":"Stedman","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2025.04.015_bib114","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1124\/dmd.108.023317","article-title":"Constitutive androstane receptor-mediated changes in bile acid composition contributes to hepatoprotection from lithocholic acid-induced liver injury in mice","volume":"37","author":"Beilke","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.ajpath.2025.04.015_bib115","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1053\/jhep.2003.50176","article-title":"The normal liver harbors the vitamin D nuclear receptor in nonparenchymal and biliary epithelial cells","volume":"37","author":"Gascon-Barre","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.04.015_bib116","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1126\/science.1070477","article-title":"Vitamin D receptor as an intestinal bile acid sensor","volume":"296","author":"Makishima","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2025.04.015_bib117","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/dmd.108.025155","article-title":"Mechanism of vitamin D receptor inhibition of cholesterol 7alpha-hydroxylase gene transcription in human hepatocytes","volume":"37","author":"Han","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.ajpath.2025.04.015_bib118","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1182\/bloodadvances.2022009618","article-title":"Secondary bile acids function through the vitamin D receptor in myeloid progenitors to promote myelopoiesis","volume":"7","author":"Thompson","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.ajpath.2025.04.015_bib119","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/hep.30937","article-title":"Vitamin D receptor activation in liver macrophages ameliorates hepatic inflammation, steatosis, and insulin resistance in mice","volume":"71","author":"Dong","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.04.015_bib120","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3748\/wjg.v17.i7.922","article-title":"Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology","volume":"17","author":"Malham","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib121","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jhep.2013.03.024","article-title":"Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease","volume":"59","author":"Trepo","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib122","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3906\/sag-2007-289","article-title":"The effect of 1,25-dihydroxyvitamin D3 on liver damage, oxidative stress, and advanced glycation end products in experimental nonalcoholic- and alcoholic- fatty liver disease","volume":"51","author":"Bingul","year":"2021","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.ajpath.2025.04.015_bib123","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.3748\/wjg.v16.i24.3016","article-title":"Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis","volume":"16","author":"Falleti","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib124","doi-asserted-by":"crossref","first-page":"544","DOI":"10.26444\/aaem\/76937","article-title":"Relationships between serum selenium and zinc concentrations versus profibrotic and proangiogenic cytokines (FGF-19 and endoglin) in patients with alcoholic liver cirrhosis","volume":"24","author":"Prystupa","year":"2017","journal-title":"Ann Agric Environ Med"},{"key":"10.1016\/j.ajpath.2025.04.015_bib125","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.livres.2022.05.001","article-title":"Effects of intestine-specific deletion of fibroblast growth factor 15 on alcoholic liver disease development in mice","volume":"6","author":"Kong","year":"2022","journal-title":"Liver Res"},{"key":"10.1016\/j.ajpath.2025.04.015_bib126","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jcmgh.2024.02.015","article-title":"Fibroblast growth factor 19 alters bile acids to induce dysbiosis in mice with alcohol-induced liver disease","volume":"18","author":"Ferrell","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib127","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/acer.14619","article-title":"Gut-restricted apical sodium-dependent bile acid transporter inhibitor attenuates alcohol-induced liver steatosis and injury in mice","volume":"45","author":"Matye","year":"2021","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.ajpath.2025.04.015_bib128","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000507","article-title":"Reversal of hepatic accumulation of nordeoxycholic acid underlines the beneficial effects of cholestyramine on alcohol-associated liver disease in mice","volume":"8","author":"Guo","year":"2024","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.ajpath.2025.04.015_bib129","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3390\/cells10061496","article-title":"Colesevelam reduces ethanol-induced liver steatosis in humanized gnotobiotic mice","volume":"10","author":"Cabre","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ajpath.2025.04.015_bib130","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib131","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2024-100104","article-title":"Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease","volume":"2","author":"Gao","year":"2024","journal-title":"eGastroenterology"},{"key":"10.1016\/j.ajpath.2025.04.015_bib132","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.alcohol.2008.08.006","article-title":"Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study","volume":"42","author":"Kirpich","year":"2008","journal-title":"Alcohol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib133","doi-asserted-by":"crossref","first-page":"12550","DOI":"10.1021\/acs.jafc.2c05591","article-title":"Transcriptomic analysis reveals lactobacillus reuteri alleviating alcohol-induced liver injury in mice by enhancing the farnesoid x receptor signaling pathway","volume":"70","author":"Cheng","year":"2022","journal-title":"J Agricultural Food Chem"},{"key":"10.1016\/j.ajpath.2025.04.015_bib134","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1002\/hep.30975","article-title":"Probiotic lactobacillus rhamnosus GG prevents liver fibrosis through inhibiting hepatic bile acid synthesis and enhancing bile acid excretion in mice","volume":"71","author":"Liu","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.04.015_bib135","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/hep.32608","article-title":"Probiotic-derived nanoparticles inhibit ALD through intestinal miR194 suppression and subsequent FXR activation","volume":"77","author":"Jiang","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.04.015_bib136","doi-asserted-by":"crossref","first-page":"968","DOI":"10.3390\/cells11060968","article-title":"Modulation of the bile acid enterohepatic cycle by intestinal microbiota alleviates alcohol liver disease","volume":"11","author":"Ciocan","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ajpath.2025.04.015_bib137","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.chom.2024.06.008","article-title":"Dietary fiber alleviates alcoholic liver injury via Bacteroides acidifaciens and subsequent ammonia detoxification","volume":"32","author":"Shen","year":"2024","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ajpath.2025.04.015_bib138","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41575-021-00536-z","article-title":"Bacteriophages and their potential for treatment of gastrointestinal diseases","volume":"19","author":"Duan","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2025.04.015_bib139","article-title":"Phage therapy: targeting intestinal bacterial microbiota for the treatment of liver diseases","volume":"5","author":"Fujiki","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.ajpath.2025.04.015_bib140","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1038\/s41467-023-39028-w","article-title":"Bacteriophage targeting microbiota alleviates non-alcoholic fatty liver disease induced by high alcohol-producing Klebsiella pneumoniae","volume":"14","author":"Gan","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2025.04.015_bib141","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1053\/j.gastro.2020.10.056","article-title":"Chronic liver diseases and the microbiome-translating our knowledge of gut microbiota to management of chronic liver disease","volume":"160","author":"Acharya","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2025.04.015_bib142","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/a-2145-7331","article-title":"Gut microbiome-centered therapies for alcohol-associated liver disease","volume":"43","author":"Ranjbarian","year":"2023","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ajpath.2025.04.015_bib143","doi-asserted-by":"crossref","first-page":"01","DOI":"10.35946\/arcr.v44.1.01","article-title":"Gut-liver-brain axis and alcohol use disorder: treatment potential of fecal microbiota transplantation","volume":"44","author":"Wolstenholme","year":"2024","journal-title":"Alcohol Res"},{"key":"10.1016\/j.ajpath.2025.04.015_bib144","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s12072-022-10312-z","article-title":"Fecal microbiota transplantation in alcohol-associated acute-on-chronic liver failure: an open-label clinical trial","volume":"16","author":"Sharma","year":"2022","journal-title":"Hepatol Int"},{"key":"10.1016\/j.ajpath.2025.04.015_bib145","article-title":"Clinical outcomes and gut microbiota analysis of severe alcohol-associated hepatitis patients undergoing healthy donor fecal transplant or pentoxifylline therapy: single-center experience from Kerala","volume":"10","author":"Philips","year":"2022","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.1016\/j.ajpath.2025.04.015_bib146","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/hep.31496","article-title":"A randomized clinical trial of fecal microbiota transplant for alcohol use disorder","volume":"73","author":"Bajaj","year":"2021","journal-title":"Hepatology"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944025001555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944025001555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:02:39Z","timestamp":1777381359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944025001555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":146,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0002944025001555"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2025.04.015","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholestasis in Alcohol-Associated Liver Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2025.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}